Serotoninergic antidepressants positively affect platelet ADAM10 expression in patients with Alzheimer's disease

ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects

(2015) Patricia Regina Manzine et al.   BIOMARKERS

The Prevalence of Depression in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

(2015) Song Chi et al.   Current Alzheimer Research

ADAM10 as a Biomarker for Alzheimer’s Disease: A Study with Brazilian Elderly

(2013) Patricia Regina Manzine et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease

(2013) Patrícia Regina Manzine et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Nardilysin, ADAM10, and Alzheimer's disease: of mice and men

(2013) Hans-Gert Bernstein et al.   NEUROBIOLOGY OF AGING

5-HT4 Receptors Constitutively Promote the Non-Amyloidogenic Pathway of APP Cleavage and Interact with ADAM10

(2012) Maud Cochet et al.   ACS Chemical Neuroscience

5-HT4 receptors, a place in the sun: act two

(2011) Joël Bockaert et al.   CURRENT OPINION IN PHARMACOLOGY

The role of G protein-coupled receptors in the pathology of Alzheimer's disease

(2011) Amantha Thathiah et al.   NATURE REVIEWS NEUROSCIENCE

5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment

(2011) Fei Shen et al.   NEUROPHARMACOLOGY

Serotonin signaling is associated with lower amyloid-  levels and plaques in transgenic mice and humans

(2011) J. R. Cirrito et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The close link between retinoid signalling and the α-secretase ADAM10 and its potential for treating Alzheimer’s disease (Commentary on Jarvis et al.)

(2010) Falk Fahrenholz   EUROPEAN JOURNAL OF NEUROSCIENCE

Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets

(2009) Filippo Caraci et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors

(2009) Luca Rozzini et al.   INTERNATIONAL PSYCHOGERIATRICS